therefore, WRO cell line were selected based on Shang and Ashley N Reeb studies (11, 12), which showed that the expression of NIS and the radioiodine uptake capacity of thyroid cancer cells in WRO were reduced. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.